Tibet Aim Pharm Inc
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; gynecology and obstetrics; and NalMefene hydrochloride injection for various acute poisoning, such as alcoh… Read more
Tibet Aim Pharm Inc (002826) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.109x
Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has a cash flow conversion efficiency ratio of 0.109x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.55 Million) by net assets (CN¥802.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tibet Aim Pharm Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Tibet Aim Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tibet Aim Pharm Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tibet Aim Pharm Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Fuanna Bedding and Furnishing Co Ltd
SHE:002327
|
0.032x |
|
Hunan Sokan New Materials Co. Ltd. A
SHG:688157
|
N/A |
|
Cheng Loong Corp
TW:1904
|
0.038x |
|
Nuvoco Vistas Corporation Limited
NSE:NUVOCO
|
0.050x |
|
Real Brokerage Inc
NASDAQ:REAX
|
0.359x |
|
Guizhou Transp Planning
SHG:603458
|
0.028x |
|
2G Energy AG
XETRA:2GB
|
-0.175x |
|
Hotai Finance Corp
TW:6592
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Tibet Aim Pharm Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Tibet Aim Pharm Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥745.58 Million | CN¥111.57 Million | 0.150x | -32.74% |
| 2023-12-31 | CN¥750.06 Million | CN¥166.88 Million | 0.222x | +143.77% |
| 2022-12-31 | CN¥750.00 Million | CN¥68.45 Million | 0.091x | -39.99% |
| 2021-12-31 | CN¥720.11 Million | CN¥109.52 Million | 0.152x | +2.73% |
| 2020-12-31 | CN¥687.15 Million | CN¥101.74 Million | 0.148x | +63.10% |
| 2019-12-31 | CN¥652.17 Million | CN¥59.20 Million | 0.091x | +321.64% |
| 2018-12-31 | CN¥618.40 Million | CN¥13.31 Million | 0.022x | -83.16% |
| 2017-12-31 | CN¥604.53 Million | CN¥77.29 Million | 0.128x | +24.19% |
| 2016-12-31 | CN¥555.44 Million | CN¥57.18 Million | 0.103x | +186.07% |
| 2015-12-31 | CN¥248.25 Million | CN¥-29.69 Million | -0.120x | -1080.84% |
| 2014-12-31 | CN¥179.12 Million | CN¥2.18 Million | 0.012x | -98.33% |
| 2013-12-31 | CN¥71.66 Million | CN¥52.24 Million | 0.729x | -- |